Nvwm, LLC Bio N Tech Se Transaction History

Nvwm, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$126.25 - $231.85 $4,418 - $8,114	-35 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$216.64 - $362.52 $1.16 Million - $1.95 Million	-5,368 Reduced 99.35%	35 $9,000
Q3 2021 Nov 03, 2021	BUY	$205.93 - $447.23 $27,182 - $59,034	132 Added 2.5%	5,403 $1.48 Million
Q2 2021 Aug 04, 2021	SELL	$113.32 - $241.49 $176,325 - $375,758	-1,556 Reduced 22.79%	5,271 $1.18 Million
Q1 2021 May 11, 2021	BUY	$85.73 - $119.5 $4,029 - $5,616	47 Added 0.69%	6,827 $745,000
Q4 2020 Feb 09, 2021	SELL	$72.71 - $129.54 $236,380 - $421,134	-3,251 Reduced 32.41%	6,780 $553,000
Q3 2020 Dec 10, 2020	BUY	$57.81 - $104.17 $1,792 - $3,229	31 Added 0.31%	10,031 $694,000
Q2 2020 Aug 11, 2020	BUY	$38.58 - $66.74 $385,800 - $667,400	10,000 New	10,000 $668,000

356

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Nvwm, LLC with notifications on news.